Rev-T is an avian retrovirus that specifically transforms early lymphoid cells in vivo and in vitro. The oncogene of Rev-T is v- rel; v-rel encodes the transforming protein p59v-rel. v-rel is derived from a normal cellular gene c-rel, and is highly related to the Drosophila dorsal gene. We are interested in the mechanism by which v-rel transforms lymphoid cells, and the reason why it does not transform fibroblast cells. Using linker insertion and in vivo mutagenesis we intend to isolate v-rel mutants that are temperature-sensitive for transformation of lymphoid cells. These mutants will be used in experiments designed to determine if p59v-rel is, or is asssociated with, a protein kinase activity important for its transforming function. If kinase activity does not seem to be important for the v-rel transforming function we will attempt to determine a pertinent biochemical function of p59v-rel using protein purified from bacterial cells expressing the v-rel protein. We will also determine the sites of phosphorylation and the identity of a second nuclear directing function in p59v- rel, and the importance of these sequences for the transforming function using site-directed mutagenesis. The avian protein p59v- rel is toxic in murine fibroblasts. We will determine the v-rel sequences responsible for this toxicity, and whether a non-toxic avian rel protein can transform murine lymphoid cells. If not, we will attempt to isolate a murine c-rel cDNA clone, and by in vitro mutagenesis we will attempt to create a dominant murine rel transforming gene. Using DNA transfer techniques, we will attempt to isolate genes from lymphoid cells that will allow transformation of fibroblast cells. Finally, by making rel-dorsal hybrid genes in retroviral vectors we will determine whether the sequence homology between these two genes also reflects a functional homology between the two proteins. The proposed studies are intended to further our understanding of retroviral transforming processes, and may have relevance to lymphoid tumor development and other normal developmental processes in general.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA047763-04
Application #
3459005
Study Section
Pathology B Study Section (PTHB)
Project Start
1988-09-01
Project End
1993-08-31
Budget Start
1991-09-01
Budget End
1992-08-31
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Boston University
Department
Type
Schools of Arts and Sciences
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Gilmore, Thomas D; Gélinas, Céline (2015) Methods for assessing the in vitro transforming activity of NF-?B transcription factor c-Rel and related proteins. Methods Mol Biol 1280:427-46
Haery, Leila; Lugo-Picó, Julián G; Henry, Ryan A et al. (2014) Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth. Mol Cancer 13:29
Thompson, Ryan C; Vardinogiannis, Iosif; Gilmore, Thomas D (2013) Identification of an NF-?B p50/p65-responsive site in the human MIR155HG promoter. BMC Mol Biol 14:24
Thompson, Ryan C; Vardinogiannis, Iosif; Gilmore, Thomas D (2013) The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activity. PLoS One 8:e62822
Yeo, Alan T; Porco Jr, John A; Gilmore, Thomas D (2012) Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis. Cancer Lett 318:53-60
Wolenski, Francis S; Chandani, Sushil; Stefanik, Derek J et al. (2011) Two polymorphic residues account for the differences in DNA binding and transcriptional activation by NF-?B proteins encoded by naturally occurring alleles in Nematostella vectensis. J Mol Evol 73:325-36
Wolenski, Francis S; Garbati, Michael R; Lubinski, Tristan J et al. (2011) Characterization of the core elements of the NF-?B signaling pathway of the sea anemone Nematostella vectensis. Mol Cell Biol 31:1076-87
Garbati, Michael R; Thompson, Ryan C; Haery, Leila et al. (2011) A rearranged EP300 gene in the human B-cell lymphoma cell line RC-K8 encodes a disabled transcriptional co-activator that contributes to cell growth and oncogenicity. Cancer Lett 302:76-83
Gilmore, Thomas D; Garbati, Michael R (2011) Inhibition of NF-?B signaling as a strategy in disease therapy. Curr Top Microbiol Immunol 349:245-63
Thompson, Ryan C; Herscovitch, Melanie; Zhao, Ian et al. (2011) NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway. J Biol Chem 286:1675-82

Showing the most recent 10 out of 14 publications